“…Likewise, traditional biosensing methods, such as florescent microarrays, lateral flow immunoassays, DNA microarrays, enzyme-linked immunosorbent assays, and polymerase chain reaction-based methods require expensive reagents and laboratory equipment, and are limited by slow signal processing methods; however, fully printed sensors allow for real time, continuous biomarker quantification in a simple, affordable, and mass producible package [ 12 , 13 ]. Printed biomolecule sensors promise a transformative way to continuously assess crucial biomarkers, making their development critical in the future of healthcare development [ 12 , 14 , 15 , 16 ]. These systems were initially fabricated with traditional micro- and nano-electromechanical systems (MEMS/NEMS) approaches, but such techniques are poorly suited for the industrial scales necessary to commercialize hybrid electronics.…”